rat anti cc1 Search Results


rat anti-cc1 , 1:200  (Becton Dickinson)
90
Becton Dickinson rat anti-cc1 , 1:200
MD1003 accelerates the differentiation potential of murine OPCs in vivo. ( A – E ) The percentage of the total Olig2+ cells (red) over Hoechst ( H in blue) increases over time for both vehicle- and MD1003-treated groups. MD1003 significantly increases the number of murine OPC at 12 wpt ( F ) and the OPC differentiation potential <t>(CC1+</t> in green) at 20 wtp ( G ) in the brain of shiverer mice. There is no effect on the percentage of Ki67+OLIG2+/Hoechst+ cells ( H ) or Ki67+OLIG2+/OLIG2+ cells ( I ). Two-way ANOVA followed by the Tukey’s multiple comparison test ( n = 5–6 mice per group). * p < 0.05, and *** p < 0.001, **** p < 0.0001. Error bars represent SEMs. WPT: weeks post-treatment; scale bar: 50 µm.
Rat Anti Cc1 , 1:200, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rat+anti+cc1/pmc09778913-24-0-5?v=Becton+Dickinson
Average 90 stars, based on 1 article reviews
rat anti-cc1 , 1:200 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


MD1003 accelerates the differentiation potential of murine OPCs in vivo. ( A – E ) The percentage of the total Olig2+ cells (red) over Hoechst ( H in blue) increases over time for both vehicle- and MD1003-treated groups. MD1003 significantly increases the number of murine OPC at 12 wpt ( F ) and the OPC differentiation potential (CC1+ in green) at 20 wtp ( G ) in the brain of shiverer mice. There is no effect on the percentage of Ki67+OLIG2+/Hoechst+ cells ( H ) or Ki67+OLIG2+/OLIG2+ cells ( I ). Two-way ANOVA followed by the Tukey’s multiple comparison test ( n = 5–6 mice per group). * p < 0.05, and *** p < 0.001, **** p < 0.0001. Error bars represent SEMs. WPT: weeks post-treatment; scale bar: 50 µm.

Journal: International Journal of Molecular Sciences

Article Title: High Dose Pharmaceutical Grade Biotin (MD1003) Accelerates Differentiation of Murine and Grafted Human Oligodendrocyte Progenitor Cells In Vivo

doi: 10.3390/ijms232415733

Figure Lengend Snippet: MD1003 accelerates the differentiation potential of murine OPCs in vivo. ( A – E ) The percentage of the total Olig2+ cells (red) over Hoechst ( H in blue) increases over time for both vehicle- and MD1003-treated groups. MD1003 significantly increases the number of murine OPC at 12 wpt ( F ) and the OPC differentiation potential (CC1+ in green) at 20 wtp ( G ) in the brain of shiverer mice. There is no effect on the percentage of Ki67+OLIG2+/Hoechst+ cells ( H ) or Ki67+OLIG2+/OLIG2+ cells ( I ). Two-way ANOVA followed by the Tukey’s multiple comparison test ( n = 5–6 mice per group). * p < 0.05, and *** p < 0.001, **** p < 0.0001. Error bars represent SEMs. WPT: weeks post-treatment; scale bar: 50 µm.

Article Snippet: Rat anti-CC1 , 1:200 , BD Pharmingen (558774).

Techniques: In Vivo

MD1003 increases the percentage of differentiated hOPCs. ( A – D ) STEM101+ human cells (red) are found in all the grafted animals 12 wpg or up to 20 wpg. ( E ) The percentage of total hOLs (OLIG2, in white) tends to increase over time, and in MD1003- vs. vehicle-treated animals. ( F ) While the percentage of OLIG2+CC1- hOPCs (CC1 in green) tends to slightly decrease overtime, MD1003-treated mice contain significantly higher numbers of differentiated OLIG2+CC1+ hOLs both at 12 wpg and 20 wpg ( G ). ( H , I ) In the oligodendroglial lineage (OLIG2+STEM+), MD1003 significantly decreases the percentage of CC1- hOPCs but increases the percentage of CC1+ hOLs. Two-way ANOVA followed by Tukey’s multiple comparison test ( n : 3–6 per groups). * p < 0.05, and ** p < 0.01. Error bars represent SEMs. WPG: weeks post graft, scale bar: 50 µm.

Journal: International Journal of Molecular Sciences

Article Title: High Dose Pharmaceutical Grade Biotin (MD1003) Accelerates Differentiation of Murine and Grafted Human Oligodendrocyte Progenitor Cells In Vivo

doi: 10.3390/ijms232415733

Figure Lengend Snippet: MD1003 increases the percentage of differentiated hOPCs. ( A – D ) STEM101+ human cells (red) are found in all the grafted animals 12 wpg or up to 20 wpg. ( E ) The percentage of total hOLs (OLIG2, in white) tends to increase over time, and in MD1003- vs. vehicle-treated animals. ( F ) While the percentage of OLIG2+CC1- hOPCs (CC1 in green) tends to slightly decrease overtime, MD1003-treated mice contain significantly higher numbers of differentiated OLIG2+CC1+ hOLs both at 12 wpg and 20 wpg ( G ). ( H , I ) In the oligodendroglial lineage (OLIG2+STEM+), MD1003 significantly decreases the percentage of CC1- hOPCs but increases the percentage of CC1+ hOLs. Two-way ANOVA followed by Tukey’s multiple comparison test ( n : 3–6 per groups). * p < 0.05, and ** p < 0.01. Error bars represent SEMs. WPG: weeks post graft, scale bar: 50 µm.

Article Snippet: Rat anti-CC1 , 1:200 , BD Pharmingen (558774).

Techniques:

List of primary antibodies used for in vivo cell characterization.

Journal: International Journal of Molecular Sciences

Article Title: High Dose Pharmaceutical Grade Biotin (MD1003) Accelerates Differentiation of Murine and Grafted Human Oligodendrocyte Progenitor Cells In Vivo

doi: 10.3390/ijms232415733

Figure Lengend Snippet: List of primary antibodies used for in vivo cell characterization.

Article Snippet: Rat anti-CC1 , 1:200 , BD Pharmingen (558774).

Techniques: In Vivo